Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPAT.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  European Journal of Pharmacology

• Publication date

  1990-08-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(90)90205-KPMID 2171956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.

  1990cited by this paper
• Evidence that the 5-HT1A receptor agonists buspirone and ipsapirone activate adrenaline release in the conscious rat.

  1990cited by this paper
• Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat

  1990cited by this paper
• Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8‐hydroxy‐2‐(di‐n‐propylamino) tetralin (8‐OH‐DPAT) in conscious rats

  1989cited by this paper
• Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.

  1989cited by this paper
• CRF activates autonomic nervous system and reduces natural killer cytotoxicity.

  1988cited by this paper
• Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.

  1988cited by this paper
• Evidence that the putative 5-HT1A receptor agonists, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetised cats.

  1987cited by this paper
• A 5-HT1-like receptor mediates a sympathetic ganglionic hyperpolarization.

  1987cited by this paper
• 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.

  1987cited by this paper
• Stimulation of corticosterone and beta-endorphin secretion in the rat by selective 5-HT receptor subtype activation.

  1987cited by this paper
• Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.

  1985cited by this paper
• Effects of corticotropin-releasing factor, neurohypophyseal peptides, and catecholamines on pituitary function.

  1985cited by this paper
• Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach

  1985cited by this paper
• Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin

  1983cited by this paper
• Pentobarbital alters compensatory neural and humoral mechanisms in response to hemorrhage.

  1982cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

  1962cited by this paper

• Effects of 5,7-dihroxytryptamine administered supraspinally or spinally on the blood glucose level in D-glucose-fed and immobilization stress models

  2016cites this paper
• 5-Hydroxytryptamine 1A (5HT1A) receptors mediate increases in plasma glucose independent of corticosterone.

  2014cites this paper
• Effect of Peripheral 5-HT on Glucose and Lipid Metabolism in Wether Sheep

  2014cites this paper
• Induction of Glucose Intolerance by Acute Administration of Rimonabant

  2012cites this paper
• Role of peripheral serotonin in glucose and lipid metabolism

  2011cites this paper
• Homeostasis of glucose in the rainbow trout (Oncorhynchus mykiss Walbaum): the role of serotonin

  2010influential citation
• Peripheral serotonin enhances lipid metabolism by accelerating bile acid turnover.

  2010cites this paper
• Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP).

  2005cites this paper
• Hyperglycemia induced by acute central fluoxetine administration: role of the central CRH system and 5-HT3 receptors.

  2004cites this paper
• Ingestive behaviors and metabolic fuels after central injections of 5-HT1A and 5-HT1D/1B receptors agonists in the pigeon.

  2004cites this paper
• Involvement of 5-HT2 Receptor in Imipramine-Induced Hyperglycemia in Mice

  2003cites this paper
• Usefulness of 5-Ht2a Receptor Antagonists for The Treatment of Cardiovascular Complications in Diabetes

  2003cites this paper
• Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice.

  2003cites this paper
• Central 5-HT3 Receptor Stimulation by m-CPBG Increases Blood Glucose in Rats

  2002cites this paper
• The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.

  2001cites this paper
• The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.

  2000cites this paper
• Enhancement of [m-methoxy3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats

  1999cites this paper
• Blockade of the anxiolytic-like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats.

  1999cites this paper
• Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms.

  1999cites this paper
• Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.

  1999cites this paper
• Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.

  1999cites this paper
• Involvement of serotonin in zimelidine-induced hyperglycemia in mice.

  1999cites this paper
• p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.

  1998cites this paper
• Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.

  1998cites this paper
• Hyperglycemia induced by the 5-HT receptor agonist, 5-methoxytryptamine, in rats: involvement of the peripheral 5-HT2A receptor.

  1997cites this paper
• Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage.

  1996cites this paper
• The oxytocin receptor antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin inhibits effects of the 5-HT1A receptor agonist 8-OH-DPAT on plasma levels of insulin, cholecystokinin and somatostatin.

  1996cites this paper
• Adrenaline release by the 5-HT1A receptor agonist 8-OH-DPAT is partly responsible for pituitary activation.

  1996cites this paper
• The effects of peripheral serotonin2 (5-HT2) and serotonin3 (5-HT3) receptor agonists on blood glucose levels in rats.

  1996cites this paper
• Effects of the 5-HT2C/2B receptor agonist 1-(3-chlorophenyl) piperazine on plasma glucose levels of rats.

  1996cites this paper
• Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.

  1996cites this paper
• Adrenalectomy does not prevent the ability of 8-OH-DPAT to decrease the ejaculatory threshold in male rats.

  1995cites this paper
• The involvement of the peripheral 5-HT2A receptor in peripherally administered serotonin-induced hyperglycemia in rats.

  1995cites this paper
• The effects of the serotonin1A receptor agonist buspirone on tolbutamide-induced hypoglycemia in rats.

  1995cites this paper
• Socially defeated male rats display a blunted adrenocortical response to a low dose of 8-OH-DPAT.

  1995cites this paper
• Central stimulation of adrenocortical secretion by 5-hydroxytryptamine1A agonists is mediated by sympathomedullary activation.

  1994cites this paper
• ICV injection of the serotonin 5-HT1B agonist CP-93,129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms.

  1994cites this paper
• Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats.

  1994cites this paper
• Central 5-HT1A receptors inhibit adrenocortical secretion.

  1993cites this paper
• Reproductive behavior in behavioral pharmacology

  1993cites this paper
• Metabolic and hormonal responses to hypothalamic administration of norfenfluramine in rats.

  1993cites this paper
• Inhibition by the serotonin1A agonist, 8-hydroxy-2- (di-n-propylamino)tetralin, of antidromically identified paraventricular nucleus neurons in the rat.

  1993cites this paper
• The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats.

  1992cites this paper
• Adrenal hormones in rats before and after stress-experience: effects of ipsapirone.

  1992cites this paper
• Central administration of 5‐HT activates 5‐HT1A receptors to cause sympathoexcitation and 5‐HT2/5‐HT1C receptors to release vasopressin in anaesthetized rats

  1992cites this paper
• Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.

  1992cites this paper
• Influence of the novel antidepressant tianeptine on neurochemical, neuroendocrinological, and behavioral effects of stress in rats.

  1992cites this paper
• Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI.

  1992cites this paper
• Role of the adrenal medulla in the metabolic and pressor actions of 8‐OH‐DPAT

  1992cites this paper
• Influence of 5-HT1A and 5-HT2 Receptor Agonists on Blood Glucose and Insulin Levels

  1991cites this paper
• Hyperglycemic properties of serotonin receptor antagonists.

  1991cites this paper
• Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucose.

  1991cites this paper
• Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.

  1991cites this paper
• Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.

  1991cites this paper
• Effects of the 5-HT1 receptor agonists DP-5-CT, CGS 12066B, and RU 24969 on plasma adrenaline and glucose levels in the rat

  1990cites this paper
• Effects of the 5-HT1C/5-HT2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat

  1990cites this paper
• Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.

  1990cites this paper